From: Uncovering steroidopathy in women with autism: a latent class analysis
Condition or symptom | Women with ASC (n = 415) | Controls (n = 415) | Unadjusted odds ratio (95% CI) | P value (Fisher's exact test, one-sided) |
---|---|---|---|---|
(sample size, if different from above) | (sample size, if different from above) | |||
n (%) | n (%) | |||
Sex-linked conditions | ||||
Anorexia | 33 (8.0%) | 10 (2.4%) | 3.50 (1.70-7.20) | 0.000 |
Congenital adrenal hyperplasia | 1 (0.2%) | 0 (0.0%) | - | 0.500 |
Diabetes | 10 (2.4%) | 14 (3.4%) | 0.71 (0.31-1.61) | 0.268 |
Epilepsy | 17 (4.1%) | 6 (1.4%) | 2.91 (1.14-7.46) | 0.016 |
Any hormonal medical condition | 43 (10.4%) | 35 (8.4%) | 1.23 (0.79-2.01) | 0.203 |
Cardiac condition | 16 (3.9%) | 5 (1.2%) | 3.29 (1.19-9.06) | 0.012 |
Thyroid condition | 35 (8.4%) | 35 (8.4%) | 1.00 (0.61-1.63) | 0.550 |
Penicillin allergy | 38 (9.2%) | 37 (8.9%) | 1.03 (0.64-1.66) | 0.500 |
Reproductive or sex steroid-related symptoms or conditions | ||||
Hirsutism | 76 (18.3%) | 61 (14.7%) | 1.30 (0.90-1.88) | 0.089 |
Irregular menstrual cycle | 192 (46.3%) | 141 (34.0%) | 1.673 (1.26-2.21) | 0.0002 |
Unusually painful periods | 163 (39.3%) | 109 (26.3%) | 1.82 (1.35-2.44) | 0.00004 |
Polycystic ovary syndrome | Â | Â | Â | Â |
Contraceptive pill users | 33 (11.8%) | 47 (14.4%) | 0.80 (0.50-1.29) | 0.212 |
 | 279 | 327 |  |  |
Contraceptive pill non-users | 11 (10.2%) | 4 (4.7%) | 2.296 (0.70-7.49) | 0.126 |
 | 108 | 85 |  |  |
Pre-menstrual syndrome | Â | Â | Â | Â |
Contraceptive pill users | 67 (24.0%) | 45 (13.8%) | 1.98 (1.30-3.01) | 0.001 |
 | 279 | 327 |  |  |
Contraceptive pill non-users | 12 (11.1%) | 7 (8.2%) | 1.39 (0.52-3.71) | 0.339 |
 | 108 | 85 |  |  |
Excessive menstrual bleeding | Â | Â | Â | Â |
Contraceptive pill users | 94 (33.7%) | 84 (25.7%) | 1.47 (1.04-2.09) | 0.019 |
 | 279 | 327 |  |  |
Non-contraceptive pill users | 22 (20.4%) | 14 (16.5%) | 1.30 (0.62-2.72) | 0.308 |
 | 108 | 85 |  |  |
Severe acne | Â | Â | Â | Â |
Contraceptive pill users | 49 (17.6%) | 41 (12.5%) | 1.49 (0.95-2.33) | 0.053 |
 | 279 | 327 |  |  |
Non-contraceptive pill users | 23 (21.3%) | 5 (5.9%) | 4.33 (1.57-11.94) | 0.002 |
 | 108 | 85 |  |  |
Timing of puberty | ||||
Delayed puberty | 4 (1.0%) | 2 (0.5%) | 2.01 (0.37-11.03) | 0.343 |
Precocious puberty | 13 (3.1%) | 2 (0.5%) | 6.68 (1.50-29.78) | 0.003 |
Early growth spurt | 84 (20.2%) | 53 (12.8%) | 1.73 (1.19-2.521) | 0.002 |
Periods after 16Â years | 28 (6.7%) | 19 (4.6%) | 1.51 (0.83-2.75) | 0.115 |
Periods before 10Â years | 34 (8.2%) | 23 (5.5%) | 1.52 (0.88-2.63) | 0.085 |
Reproductive cancers | ||||
Breast cancer | 17 (4.1%) | 15 (3.6%) | 1.14 (0.56-2.31) | 0.429 |
Family history of breast cancer | 97 (23.4%) | 106 (25.5%) | 0.89 (0.65-1.22) | 0.259 |
Ovarian cancer | 9 (2.2%) | 12 (2.9%) | 0.74 (0.31-1.79) | 0.330 |
Family history of ovarian cancer | 49 (11.8%) | 41 (9.9%) | 1.22 (0.79-1.90) | 0.217 |
Family history prostate cancer | 39 (9.4%) | 44 (10.6%) | 0.88 (0.56-1.34) | 0.322 |
Uterine cancer | 17 (4.1%) | 12 (2.9%) | 1.43 (0.68-3.04) | 0.225 |
Family history uterine cancer | 43 (10.4%) | 34 (8.2%) | 1.30 (0.81-2.08) | 0.169 |
Gender and sexuality | Â | Â | Â | Â |
Tomboyism | 371 | 404 | Â | Â |
 | 252 (67.9%) | 171 (42.3%) | 2.885 | 0.0000 |
Gender dysphoria | 320 | 396 | Â | Â |
 | 12 (3.8%) | 1 (0.3%) | 15.39 | 0.0004 |
Sexual preference | Â | Â | Â | Â |
 | 414 | 415 |  | 0.000* |
Male | 261 (63.0%) | 369 (88.9%) | Â | Â |
Female | 48 (11.6%) | 28 (6.7%) | Â | Â |
Both | 57 (13.8%) | 18 (4.3%) | Â | Â |
Neither | 48 (11.6%) | 0 (0.0%) | Â | Â |
Transsexual | 102 | 52 | Â | Â |
 | 12 (11.8%) | 1 (1.9%) | 6.80 (0.86-53.82) | 0.030 |
Obstetric conditions | ASC (parous) | Controls (parous) | Â | Â |
 | 185 | 264 |  |  |
Miscarriage | 56 (30.3%) | 65 (24.6%) | 1.33 (0.87-2.02) | 0.111 |
Pre-eclampsia | 12 (6.5%) | 17 (6.4%) | 1.01 (0.47-2.16) | 0.565 |
Difficulty conceiving | 25 (13.5%) | 51 (19.3%) | 0.65 (0.39-1.10) | 0.068 |